About
Looking for more information?
Contact our responsive and friendly client services team any time.
(03) 9028 2888
clients@freshequities.com
INVESTOR PRESENTATION - AdAlta Limited
AdAlta Limited
Health
AdAlta is an innovative biotech company developing a unique range of new drug treatments. AdAlta has pioneered a technology that mimics the shape and stability of a crucial antigen-binding domain, discovered initially in sharks and then developed as a human protein. The result is a range of unique compounds, now known as i-bodies, for use in treating serious diseases. AdAlta is utilising the power of the i-body technology to create a pipeline of new drugs, with an initial focus on treating fibrotic diseases.
Read moreMarket Cap
$35.55m
Price at Close
$0.145
4w avg. Volume
441.17k
4w avg. Turnover
$60.73k
Announcements
| announcement | t+2 movement | date |
|---|---|---|
| -7.69% | 13 Dec 2020 |
| 0.00% | 29 Nov 2020 |
| 0.00% | 26 Nov 2020 |
| 0.00% | 25 Nov 2020 |
| 0.00% | 24 Nov 2020 |
| 0.00% | 23 Nov 2020 |
| -4.35% | 08 Nov 2020 |
| -8.00% | 26 Oct 2020 |
| +3.70% | 21 Oct 2020 |
| +3.70% | 21 Oct 2020 |
Market Data
Current Price
$0.145
52WK HIGH
$0.185
52WK LOW
$0.04
1YR RETURN
+31.82%
1YR RETURN VS. SECTOR
-5.70%
90 DAY RETURN
+11.54%
ASX RANK
1,299
/2,047
SECTOR RANK
123
/168
SHARES OUTSTANDING
245.18m
AdAlta Limited
Health
AdAlta is an innovative biotech company developing a unique range of new drug treatments. AdAlta has pioneered a technology that mimics the shape and stability of a crucial antigen-binding domain, discovered initially in sharks and then developed as a human protein. The result is a range of unique compounds, now known as i-bodies, for use in treating serious diseases. AdAlta is utilising the power of the i-body technology to create a pipeline of new drugs, with an initial focus on treating fibrotic diseases.
Read moreMarket Cap
$35.55m
Price at Close
$0.145
4w avg. Volume
441.17k
4w avg. Turnover
$60.73k
ASX:1AD is not raising right now
Want to invest?
Contact Us
(03) 9028 2888
clients@freshequities.com
Address
Level 7, 388 Bourke St
Melbourne VIC 3000
Australia